SCHEMBL4902605

SCHEMBL4902605

COC(=O)c1cc(S(=O)(=O)NCCSc2ccc(-c3ccccc3)nn2)cc(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
HPGD P15428 4/20 0.41
LMNA P02545 3/20 0.41
MAPT P10636 7/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC12A2 P55011 1/20 0.39
SLC12A5 Q9H2X9 1/20 0.39
HCRTR1 O43613 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 3/20 0.38
HSD17B10 Q99714 1/20 0.38
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905821 0.92 MAPT (0.43) ALDH1A1HPGDLMNAMAPTCA1
SCHEMBL4906189 0.91 LMNA (0.45) ALDH1A1HPGDLMNAMAPTCA1
SCHEMBL4894575 0.83 LMNA (0.54) ALDH1A1HPGDLMNAMAPTCA1
SCHEMBL4901797 0.82 TSHR (0.48) ALDH1A1HPGDLMNAMAPTSMN1; SMN2
SCHEMBL4902616 0.78 RXFP1 (0.37) ALDH1A1HPGDLMNAMAPTCA1
SCHEMBL4904118 0.76 SMN1; SMN2 (0.52) ALDH1A1HPGDLMNAMAPTSMN1; SMN2
SCHEMBL4902784 0.76 ALDH1A1 (0.48) ALDH1A1LMNAMAPTCA2L3MBTL1
SCHEMBL4904998 0.75 ALDH1A1 (0.47) ALDH1A1LMNAMAPTTSHRHSD17B10
SCHEMBL4905491 0.73 RAB9A (0.45) ALDH1A1HPGDLMNAMAPTSMN1; SMN2
SCHEMBL4898005 0.73 MAPT (0.47) ALDH1A1LMNAMAPTL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885HPGD 696/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.